Clinical Trial Update: A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) [Phase 2]

View source ↗

Summary

Phase 2 trial of degarelix for lower urinary tract symptoms due to benign prostatic hyperplasia has been completed, with results posted on 2015-05-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Lower Urinary Tract Symptoms (LUTS) | Phase 2 | Status: COMPLETED | Results posted: 2015-05-14